SOPHARMA (SPH): Sales revenues for June 2019 - raport 32
Raport ESPI
UNI - EN REPORT No
32
/
2019
UNI - EN REPORT No32/2019
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that for June 2019 the Company recorded an increase in sales of 1% compared to the same month of 2018, incl. 6% decrease in sales for the domestic market and 7% growth in export sales.
